Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
antibody, appointed, Australia, avelumab, behalf, beneficial, Berk, capability, care, cellular, central, Certification, Chiapponi, chosen, classification, closeout, collaboration, compound, doubt, Dr, duly, encoded, enhancing, entertainment, entity, forfeiture, gemcitabine, gene, Green, Gregory, herewith, highly, immunity, improve, indefinite, Index, inhibition, inhibitory, Jack, Joe, John, KGaA, lease, local, lymphoma, Medical, Merck, metastatic, microenvironment, modulating, orally, pan, pancreatic, pathway, Payment, pembrolizumab, Pfizer, poorer, potent, President, principal, proliferation, put, real, resigned, returned, role, selective, single, Subtopic, survival, thereunto, today, Treasurer, tyrosine, undersigned, Vice
Filing tables
Filing exhibits
VSTM similar filings
Filing view
External links